¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Auditory disease, central"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • iatrogenic disease
    ÀÇÀκ´, ÀÇ¿øº´
  • iron-storage disease
    öÃàÀûÁúȯ
  • ischemic bowel disease
    ÇãÇ÷Àå¿°, ÇãÇ÷âÀÚ¿°
  • ischemic heart disease
    ÇãÇ÷½ÉÀ庴
  • immune deposit disease
    ¸é¿ªÄ§Âøº´
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
  • immunodeficiency disease
    ¸é¿ª°áÇ̺´
  • immunological disease
    ¸é¿ªº´, ¸é¿ªÁúȯ
  • immunoproliferative disease
    ¸é¿ª¼¼Æ÷Áõ½Äº´, ¸é¿ªÁõ½ÄÁúȯ
  • imported disease
    ¼öÀÔº´
  • inclusion disease
    Æ÷ÇÔüº´, ºÀÀÔüº´
  • industrial disease
    »ê¾÷º´
  • infectious disease
    °¨¿°º´
  • inflammatory bowel disease
    ¿°ÁõâÀÚÁúȯ, ¿°Áõ¼ºÀåÁúȯ
  • idiopathic disease
    Ư¹ßº´, Ư¹ß¼ºÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • immunological disease
    ¸é¿ªÁúȯ
  • immunoproliferative disease
    ¸é¿ª¼¼Æ÷Áõ½Äº´
  • imported disease
    ¼öÀÔº´
  • inclusion disease
    Æ÷ÇÔº´, ºÀÀÔº´
  • industrial disease
    »ê¾÷º´, Á÷¾÷º´
  • infectious disease
    °¨¿°º´
  • inflammatory bowel disease
    ¿°ÁõâÀÚº´, ¿°ÁõÀ庴
  • inherited disease
    À¯Àüº´
  • insect-borne disease
    °ïÃæ¸Å°³º´
  • integumentary disease
    ¿ÜÇÇÁúȯ
  • intercurrent disease
    º´¹ßÁúȯ
  • interstitial disease
    °£Áú¼ºº´, »çÀÌÁúº´
  • intestinal disease
    âÀÚº´, À庴
  • irreversible obstructive lung disease
    ºñ°¡¿ªÆó¼âÆóº´
  • ischemic bowel disease
    (¢¡ischemic colitis) ÇãÇ÷Àß·èâÀÚ¿°, ÇãÇ÷°áÀå¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • gastric vertigo =trousseau disease
    À§(¼º)Çö±â
  • gauchers disease
    °í½¦º´, Gaucher º´
  • generalized obstructive lung disease
    ¹ü¹ß¼º Æó¼â¼º ÆóÁúȯ(ÛñÛ¡àõøÍáð
  • gestational trophoblastic disease
    Àӽżº¿µ¾ç¸ð¼¼Æ÷Áúȯ(¡­ç½å×Ù½á¬øàòðü´)
  • glomerular disease
    »ç±¸Ã¼Áúº´
  • glomerular disease
    »ç±¸Ã¼Áúȯ(ÞêϹô÷òðü´)
  • glucose storage disease
    ´çÃàÀûÁúȯ.
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´.
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • central sequestrum
    Á᫐ ºÎ°ñ(ñéãýݯÍé).
  • central serous chorioretinopathy
    Á߽ɼºÀå¾×¸Æ¶ô¸Á¸·º´Áõ
  • central serous choroidopathy
    Á߽ɼºÀå¾×¸Æ¶ô¸·º´Áõ
  • central serous retinopathy
    Á߽ɼºÀå¾×¸Á¸·º´Áõ
  • central speckled corneal dystrophy
    Á߽ɼº¹ÝÁ¡°¢¸·ÀÌ¿µ¾ç(Áõ)
  • central sulcus
    Á߽ɰí¶û, Á߽ɱ¸(ñéãýϵ).
  • central sulcus
    Á߽ɰí¶û
  • central sulcus of insula
    ¼¶Á߽ɰí¶û
  • central suppression
    Á߽ɾïÁ¦
  • central tegmental fascicle
    Áß½ÉÇǰ³¼Ó(¡­ù¬ËÏáÖ).
  • central tegmental tract
    Áß½ÉµÚÆÇ·Î
  • central tendon
    Á¤¿Ü Á߽ɳÎÈûÁÙ, Á߽ɰÇ.
  • central tendon
    Á߽ɳÎÈûÁÙ
  • central thalamic radiations
    Á߽ɽûóºÎê»ì
  • central trigeminal neuralgia
    ¸¶ÃëÁßÃß¼º »ïÂ÷½Å°æÅë(ñéõÒàõß²ó©ãêÌè÷Ô).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
ASHCSP American Society for Hospital Central Service Personnel [of AHA]
CAHS central alveolar hypoventilation syndrome
CAHV central alveolar hypoventilation
CAP camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab...
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
CEA central amygdaloid nucleus
CCN central cervical nucleus
CL central lateral
CL central lateral nucleus
CN central nucleus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • liver disease
    °£ Áúȯ
  • lung disease
    Æó Áúȯ
  • lymphoproliferative disease
    ÀÓÆÄ ¼¼Æ÷ Áõ½Ä¼º Áúȯ
  • Majocci's disease
    ¸¶¿äŰ º´
    Àڹݺ´.
  • Malassez's disease
    ¸»¶ó¼¼ º´
    °íȯÀÇ ³¶Æ÷.
  • manager disease
    ¸Å´ÏÀú º´
    ¿©·¯ °¡Áö º¹ÀâÇÑ ¾÷¹«¿¡ ¹Ù»Ú°Ô ½Ã´Þ¸®´Â °ü¸® Á÷±ÞÀÇ »ç¶÷¿¡°Ô¼­ ÈçÈ÷ º¼ ¼ö ÀÖ´Â º´. Çù½ÉÁõ, ƯÈ÷ °ü»ó µ¿¸Æ Ç÷ÀüÁõ µîÀÇ ½ÉÀå Ç÷°ü°è Áõ¼¼µé¸¸À» °¡¸®Å°´Â °ÍÀ̾ú´Âµ¥ Á¡Â÷·Î È®´ëµÇ¾î ¼ÒÈ­¼º ±Ë¾ç, ´ç´¢º´, ³ëÀÌ·ÎÁ¦, Ç÷¾Ð Àå¾Ö µîµµ Æ÷ÇԵȴÙ.
  • maple syrum urine disease
    ´Üdz ³ª¹« ½Ã·´ º´
    Ãø¼â, ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê
  • maple syrup urine disease
    ´Üdz ´ç¹Ð ´¢ Áúȯ
    Ãø¼â ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê[valine, leucine, isoleucine]ÀÇ ½ÉÇÑ Áõ°¡¸¦ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÀû Ư¡Àº Á¤½Å Áöü ¹ß´Þ Áö¿¬, Æ÷À¯ °ï¶õ, ¿äÃë µîÀÌ´Ù.
  • marble bone disease
    °ñ È­¼®Áõ, ´ë¸®¼® °ñº´
    ´ß ¹éÇ÷º´ À°Á¾±º¿¡ ¼ÓÇÏ´Â º´. °ñÇü ¸²ÇÁÁ¾À̶ó°íµµ ÇÏ´Â ÀÌ º´Àº, »À°¡ ±½¾îÁö´Â °ÍÀÌ Æ¯Â¡À̸ç, ¹ß»ýÀÌ µå¹°±â ¶§¹®¿¡ °æÁ¦ÀûÀ¸·Î Å« ¶æÀº ¾ø´Ù. Ç÷±¸¿Í ÀüÇô °ü°è¾øÀÌ »À ¼¼Æ÷°¡ Áõ½ÄÇϹǷΠÇ÷±¸¿¡¼­ À¯·¡ÇÏ´Â Á¾¾çÀÌ ¾Æ´Ï¶ó, ¹éÇ÷º´°ú °°Àº ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ÀϾ´Â º´À̱⠶§¹®¿¡ ¹éÇ÷º´À¸·Î Ãë±ÞµÈ´Ù.
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ì º´
    ³ú·®ÀÇ ÁøÇ༺ ÅðÇà º¯¼ºÀ¸·Î¼­ ÁøÇ༺ ÁöÀû ȲÆó, Á¤¼­ Àå¾Ö, Âø¶õ, ȯ°¢, ÁøÀü, °­Á÷, °æ·ÃÀÌ Æ¯Â¡. ÁÖ·Î Á߳⠳²ÀÚ Áß ¾ËÄÝ Áßµ¶ÀÚ, ƯÈ÷ ´Ù·®ÀÇ »ýÆ÷µµÁÖ¸¦ ¸¶½Ã´Â »ç¶÷¿¡°Ô Àß °É¸®´Â µå¹® Áúº´ÀÌ´Ù.
  • Marek's disease
    ¸¶·¹Å© º´
    Æ÷Áø ¹ÙÀÌ·¯½º
  • margarine disease
    ¸¶°¡¸° º´
    ´ÙÇü¼º È«¹ÝÀ¸·Î¼­ oleomargarineÁßÀÇ À¯È­Á¦°¡ ¿øÀÎÀÌ´Ù. µ¶ÀÏ, ¿À¶õ´Ù¿¡¼­ Æø¹ßÀûÀ¸·Î À¯ÇàÇÏ¿´À¸¸ç ´ç½Ã´Â Àü¿°¼ºÀ̶ó°í »ý°¢Çß´Ù.
  • medullary cystic disease
    ¼öÁú³¶¼º Áúȯ
  • mental disease
    Á¤½Åº´
    ±â´ÉÀû ¿øÀΰú ±âÁúÀûÀÎ ¿øÀÎÀ» Æ÷ÇÔÇÑ ¸ðµç Á¤½Åº´.
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
asbestos lung disease <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy
(12 Dec 1998)
asherman disease <radiology> Uterine synechiae, linear, lucent defects in uterus on HSG, usually secondary to endometrial trauma (D&C, etc.)
(12 Dec 1998)
atherosclerotic vascular disease <cardiology> The progressive narrowing and hardening of the arteries over time. This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
Aujeszky's disease A highly contagious herpes virus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.
(12 Dec 1998)
Aujeszky's disease virus A herpesvirus causing pseudorabies in swine.
Synonym: Aujeszky's disease virus.
(05 Mar 2000)
Australian X disease A severe encephalitis with a high mortality rate occurring in the Murray Valley of Australia; the disease is most severe in children and is characterised by headache, fever, malaise, drowsiness or convulsions, and rigidity of the neck; extensive brain damage may result; it is caused by the Murray Valley encephalitis virus (genus Flavivirus).
Synonym: Australian X disease, Australian X encephalitis.
(05 Mar 2000)
Australian X disease virus A group B arbovirus of the genus Flavivirus that causes Murray Valley encephalitis; it is transmitted by Culex mosquitoes, and also infects birds and horses.
Synonym: Australian X disease virus, MVE virus.
(05 Mar 2000)
autoimmune disease <disease> A disease process that involves the production of host antibodies to host tissue.
(27 Sep 1997)
aviator's disease Syndrome resembling decompression sickness occurring in occupants of airplanes that reach very high altitudes without adequate pressurization of the cabin.
See: decompression sickness.
(05 Mar 2000)
Ayerza's disease <syndrome> Sclerosis of the pulmonary arteries in chronic cor pulmonale; associated with severe cyanosis, it is a condition resembling polycythemia vera but resulting from primary pulmonary arteriosclerosis or primary pulmonary hypertension and characterised by plexiform lesions of arterioles.
Synonym: Ayerza's disease, cardiopathia nigra, plexogenic pulmonary arteriopathy.
(05 Mar 2000)
Azorean disease A rare form of hereditary ataxia, characterised by onset in early adult life of progressive, spinocerebellar and extrapyramidal disease with external ophthalmoplegia, rigidity dystonia symptoms, and, often, peripheral amyotrophy; found predominantly in people of Azorean ancestry; autosomal dominant inheritance.
Synonym: Azorean disease, Portuguese-Azorean disease.
Origin: Surnames of two families studied in major descriptions of the disease.
(05 Mar 2000)
bacterial wilt disease <botany> A plant disease common in cucumber and muskmelon caused by the bacteria Erwinia tracheiphila which causes wilting and shriveling of the stems and leaves.
(09 Oct 1997)
Baelz' disease An acquired disorder, of unknown aetiology, of the lower lip characterised by swelling, ulceration, crusting, mucous gland hyperplasia, abscesses, and sinus tracts.
Synonym: Baelz' disease, myxadenitis labialis, Volkmann's cheilitis.
(05 Mar 2000)
Balo's disease Encephalitis that is clinically similar to adrenoleukodystrophy, but pathologically characterised by concentric globes or circles of demyelination of cerebral white matter separated by normal tissue.
Synonym: Balo's disease.
(05 Mar 2000)
Baltic myoclonus disease One of the familial light sensitive myoclonic epilepsies. Unlike Lafora body polymyoclonus, where inclusion bodies are seen in the brain cells, the prognosis is often favourable. Probably an autosomal recessive disorder.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á